World Lupus Day is an initiative to increase the awareness around this disease which affects more than 5 million people worldwide. Last week in Paris, the biotech company Neovacs, which develops an innovative therapy against lupus, had gathered researchers, entrepreneurs and patients’ associations who are fighting the disease. I was there to meet them and learn more about lupus.
Lupus is one of the most common rare diseases, with a prevalence ranging from 4 to 6 in 10,000 people depending on the country (in some countries it’s not considered as a rare disease because prevalence is above the limit of 5/10,000).
Despite the high number of cases, effective treatments against lupus are still missing, and this is mainly because of the complexity of the disease.
Lupus: a complex disease, hard to understand
Lupus is an autoimmune disease caused by a deregulation of the immune system. Usually, after our cells undergo apoptosis and release nucleic material in our body, the macrophages are able to effectively clean it up.